New Delhi: The Central Government has ordered a 30 crore dose of the Biological-E vaccine, the second vaccine developed in India. Production will take place from August to December this year.

The health ministry has said that Rs 1,500 crore for the vaccine will be released in the next few days.Biological E is the second vaccine to be developed after Bharat Biotech’s covaxin.The biological E is for the RBD protein subunit vaccine. The third phase of the vaccine is being tested in India.

The application of Biological E was discussed and approved by the National Expert Group.The press release states that the Central Government has been supporting the experiments of Biological E since the first phase of testing. In addition, Rs 100 crore was given as a grant-in-aid.The money was handed over as part of Mission covid security.There are currently three vaccines available in India. Covaxin, which is developed by India Covisheild of the Serum Institute and Sputnik 5 made in Russia.

New Delhi: Oman has been extended the ban on Indian travelers in the wake of the Covid expansion. Oman Supreme Committee has been extended the ban on international flights from India. Besides India, Pakistan, Bangladesh, Egypt, Phillippines, Brazil has been ban from entering Oman, reports said.

A ban has been imposed on the International flight on April 25. And it was extended indefinitely. The travelers directly from India and those who stayed in India for 14 days were also banned, reports said. 

New Delhi: The Drugs Controller has granted exemption to norms to ensure availability of foreign vaccines to expedite vaccination in the country. For this, the Drug Controller omitted the indigenous vaccine testing and the permission required by the Central Drugs Laboratory for each batch of vaccine.

Currently, vaccines need to be tested in the country before foreign vaccines can be approved for immediate use. However, the relaxation in the norms was allowed to ensure the availability of the vaccine in the country.

Drug controller exemptions are granted for vaccines approved at various levels, including the FDA in the United States, the European Medicines Agency, the UK MHRA, the PMDA Japan, and the World Health Organization’s Emergency Use List.

New Delhi: The CBSE Plus Two exams has been cancelled in the country due to Covid expansion. The decision was taken at a meeting convened by Prime Minister Narendra Modi. The CBSE Plus One exam had been canceled earlier. The Plus Two exam was canceled due to the expansion of Covid and the lockdown in the states. Kerala had said that the examination could be held to ensure security.

The Class 10 exams were cancelled and Class 12 exams postponed following the second wave of Covid. The apex court was asked to respond on Thursday to a petition seeking cancellation of the postponed exams. The Prime Minister called the meeting in the wake of this. Ministers Prakash Javadekar and Rajnath Singh also attended the meeting.

Thiruvananthapuram: Railways has started service of more trains. Several trains were canceled until May 31. Memu and Express trains resumed service after this period.

06013/06014 Alappuzha-Kollam-Alappuzha Memu, 06015/06016 Ernakulam-Alappuzha-Ernakulam Memu and 06017/06018 Shornur-Ernakulam-Shornur Memu will resume service from Tuesday.

The Kochuveli-Nilambur Rajyarani train will leave Kochuveli on Tuesday.06350 Nilambur-Kochuveli train will leave Nilambur on Wednesdays.

06167/06168 Thiruvananthapuram-Hazrat Nizamuddin-Thiruvananthapuram, 06161/06162 Ernakulam-Banaswadi-Ernakulam, 02646/02645 Kochuveli-Indore-Kochuveli, 06164/06163 Kochuveli-Lomanyathilak-Kochuveli and 06336 06335 have been started in Nagercoil-Gandhidham.

New Delhi: The first batch of Sputnik, a Russian – made Covid vaccine, has been approved for distribution. With this, it is hoped that Covid vaccination will be expedited in the country. The Central Drugs Laboratory has given the green light to the first batch of Sputnik vaccines made in India.

Sputnik is currently manufactured in India by six Indian companies. The first batch of Sputnik vaccines, manufactured by Hyderabad-based Hetro Drugs, has been approved for distribution. In April, the Drug Controller approved the Sputnik vaccine for immediate use.
The Russian delegation said that 70 percent of the Sputnik vaccine distributed worldwide comes from India. Indian companies are preparing to produce 85 million doses of the Sputnik vaccine. Russia, meanwhile, has imported 2,10,000 doses of the Sputnik vaccine into India.

New Delhi: Center with intensive measures to expedite Covid immunization. According to the Ministry of Health, by July, one crore people will be vaccinated every day. Efforts are also underway to deliver higher doses of foreign vaccines.

The center aims to vaccinate everyone over the age of 18 before the third wave. It is claimed that the vaccination will be completed by December. The Ministry of Health has announced that 12 crore doses of the vaccine will be available this month and one crore doses per day by mid-July. Covishield and Covaxin will increase production.

Cipla, a pharmaceutical company, has asked the center to expedite the delivery of Moderna’s booster vaccine. Concessions should be made on pricing, customs duty, and vaccine testing.

Cipla has also informed the Center that it will sign a Rs 7,250 crore deal with Moderna. Moderna had said that India could be vaccinated next year. The Center has directed the states to increase the number of vaccination centers and to accurately record information on vaccine availability.